已收盤 06-18 16:00:00 美东时间
+2.010
+3.18%
今日重点评级关注:瑞杰金融:上调InflaRx评级至"强烈买入",目标价从7美元升至9美元;巴克莱:维持Orchestra BioMed Hldgs"超配"评级,目标价从12美元升至13美元
05-14 14:32
Keefe, Bruyette & Woods analyst Sanjay Sakhrani maintains Nayax (NASDAQ:NYAX) with a Market Perform and raises the price target from $60 to $75.
05-13 22:20
Nayax (NASDAQ:NYAX) reported first-quarter financial results on Tuesday. The tr...
05-12 23:47
Nayax LTD. press release (NYAX):Q1 Revenue of $106.9M. Operating profit was $4.1 million compared to $7.9 million. Q1 2025 included a one-time gain of approximately $6.1 million related to Nayax’s sha...
05-12 20:38
Nayax (NASDAQ:NYAX) affirms FY2026 sales outlook from $510.000 million-$520.000 million to $510.000 million-$520.000 million vs $514.601 million estimate.
05-12 19:34
Nayax (NASDAQ:NYAX) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.09 by 66.67 percent. This is a 84.21 percent decrease over earnings of $0.19 per share from the same
05-12 19:30
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
今日重点评级关注:Oppenheimer:维持Corbus制药控股"跑赢大市"评级,目标价从53美元升至57美元;Canaccord Genuity:维持WAVE Life Sciences"买入"评级,目标价从43美元升至52美元
03-11 12:40
Keefe, Bruyette & Woods analyst Sanjay Sakhrani maintains Nayax (NASDAQ:NYAX) with a Market Perform and raises the price target from $52 to $60.
03-10 20:23